Status:
COMPLETED
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Hepatitis C
Substance Use Disorders
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate c...
Detailed Description
The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate c...
Eligibility Criteria
Inclusion
- Patient has confirmed diagnosis of HCV;
- Patient has expressed an interest in undergoing interferon treatment;
- Patient is deferred from interferon therapy for psychiatric, alcohol use, or other psychosocial issues;
- Patient must be completely medically cleared by the hepatologist with no outstanding medical conditions that would deem them ineligible from treatment;
- Patient must have only psychiatric issues and/or substance use issues; but otherwise no other contraindications for treatment.
Exclusion
- Patient has a diagnosis of schizophrenia, psychosis;
- Patient resides in a psychiatric residential facility;
- Patient attempted suicide in the past five years;
- Patient is a current intravenous drug user;
- Patient is cognitively or decisionally-impaired due to brain disease or injury;
- Patient has advanced liver disease that precludes them from interferon treatment;
- Patient has other medical comorbidities that may exclude them from interferon treatment;
- Patient does not want to pursue interferon treatment at the present time;
- Patient has significant financial constraints, such as no insurance or homelessness, that would prevent them acquiring mental health or substance abuse services;
- No access to telephone service;
- Non-English speaking.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00407732
Start Date
January 1 2007
End Date
October 1 2011
Last Update
January 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity of North Carolina
Chapel Hill, North Carolina, United States, 27599